Tilray Brands (TLRY) EPS (Diluted) Growth (1y) (2020 - 2026)
Tilray Brands (TLRY) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Tilray Brands | 516.67 Mn | 282.03 Mn | 90.52 Mn | 97.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 97.39% |
| Feb 28, 2026 | 97.44% |
| Nov 30, 2025 | 60.00% |
| Aug 31, 2025 | 103.61% |
| May 31, 2025 | -8,189.35% |
| Feb 28, 2025 | -527.80% |
| Nov 30, 2024 | -56.00% |
| Aug 31, 2024 | 51.03% |
| May 31, 2024 | -95.63% |
| Feb 29, 2024 | 92.84% |
| Nov 30, 2023 | 54.55% |
| Aug 31, 2023 | 29.33% |
| May 31, 2023 | 137.18% |
| Feb 28, 2023 | -1,908.60% |
| Nov 30, 2022 | -1,204.02% |
| Aug 31, 2022 | -48.52% |
| May 31, 2022 | -177.45% |
| Feb 28, 2022 | -28.73% |
| Nov 30, 2021 | 103.44% |
| Aug 31, 2021 | 14.30% |